CEO Today USA Awards 2021

36 CEO of Rowpar Pharmaceuticals, Inc. About James Ratcliff James L. Ratcliff, Ph.D. is Chairman of the Board and CEO of Rowpar Pharmaceuticals, Inc., Scottsdale, AZ, maker of the ClōSYS brand of oral care products. Dr. Ratcliff is a driving force behind expansion of the company’s product line and its penetration of global markets. Dr. Ratcliff is the second generation of the Ratcliff family leading Rowpar. Prior to joining the company as Chairman and CEO in 2000, Dr. Ratcliff served as senior research scientist, professor, and director of the Center for the Study of Higher Education at Pennsylvania State University. From 1979 to 1989, Dr. Ratcliff served as professor and program head for higher education at Iowa State University. Dr. Ratcliff is author of 120 articles, books, and book chapters, and is the co-inventor on over 30 patents and patents pending. He is an active member of the Arizona Biotechnology Association, American Academy of Oral and SystemicHealth, AmericanEducationResearch Association, and the International Association for Dental Research. He holds a Ph.D. in Higher Education from Washington State University, a M.A. in History from Washington State University, and a B.A. from Utah State University. Headquartered in Scottsdale, Arizona since 1991, Rowpar Pharmaceuticals, Inc. is an organization dedicated to providing innovative oral health solutions; ClōSYS® Oral Health products help people live healthier lives. Originally envisioned as a company selling a boutique product line exclusively to dentists, Rowpar competes successfully in the world of fast-moving consumer goods, both nationally and internationally. With a team of fewer than a dozen seasoned professionals, Rowpar thrives in a world dominated by firms such as Colgate-Palmolive, Proctor & Gamble, and GlaxoSmithKline. Having broken new ground, ClōSYS products are dispensed by Novartis USA to Afintior™ (breast cancer prescriptions) to counteract medically induced oral sores. Dr. Perry Ratcliff, one of America’s leading periodontists and experts on dental health and gum disease, along with a team of leading dental professionals, created ClōSYS in 1991. During the senior Dr. Ratcliff’s 50-plus years of clinical practice, he observed that stabilized chlorine dioxide helped reduce harmful bacteria, fungi, viruses and plaque in the mouths of his patients, a discovery that has evolved into the patented formula Cloralstan® that makes ClōSYS unique, safe and effective. Dr. Perry Ratcliff remained active in Rowpar’s development until the year 2000. Rowpar provides innovative oral health solutions to dental and medical professionals and the general consumer, helping people get well and staywell inNorthAmerica, Europe, Australia, andAsia. The ClōSYS® brand is recommended by dentists and hygienists, doctors and nurses, and is among the top 10% of oral care products stocking the shelves in CVS, Walgreens, Walmart, and Amazon nationally with new retailers, new stores, and new shelves continually being added. Since 2019, Rowpar has offered the first oral care system (toothpaste and oral rinse) specially formulated for adults 55+, comprising ClōSYS® Silver Toothpaste and ClōSYS® Silver Rinse. Seniors are prone to adult caries, xerostomia and periodontal disease in epidemic proportions. These diseases compromise the immune system, leaving seniors vulnerable to chronic, infectious systemic diseases. James Ratcliff AR I ZONA

RkJQdWJsaXNoZXIy Mjk3Mzkz